I-sarcoma ye-soft soft

Ezingxenyeni ezithambile zomzimba wethu, izicubu zenzeka kaningi, kepha iningi lazo lihle. I-sarcoma ye-Soft isifo esiyinqaba esingavamile, esibala cishe u-0.6% wezingqikithi eziningi ze-neoplasms ezimbi. Kodwa i-sarcoma iyingozi kakhulu, njengoba iqala ngokushesha kakhulu.

Izimbangela zokuthuthukiswa kwe-tissue sarcoma

Kunezici eziningi zokucasula, kodwa okokuqala kudingekile ukuba ucabange ukuthi i-inherited properties isifo somdlavuza. Kwabuye kwaphawula ukuthi i-sarcoma ithinta amadoda ngaphezu kwabesifazane. Isilinganiso seminyaka yeziguli uneminyaka engama-40 futhi iguquke kuzo zombili izinkomba cishe eminyakeni engu-10-12. Nazi izizathu ezivame kakhulu eziholela ekukhuleni kwesisu esinonya ezinhlobonhlobo ezithambile:

Ngenxa yokuthi izicubu ezithambile (imisipha, uhla lwe-fat, amaqoqo ezitsha) azihlobene kakhulu nomsebenzi wezitho zangaphakathi, ukuxilongwa kunzima. I-tumor ngokwayo ingatholakaliswa ngosizo lwe-ultrasound, tomography, i-MRI nezinye izindlela, kepha ukucacisa ukuthi ngabe i-sarcoma izovumela kuphela i-biopsy. Ngaphezu kwalokho, ngamacala angu-90%, ukukhula kwanoma yikuphi ukulimala ezinyangeni ezimbalwa zokuqala kuphelele ngokuphelele. Izibonakaliso eziyinhloko ze-tissue sarcoma yizi:

Ezinye izibonakaliso ze-sarcoma yezicubu ezithambile zihlotshaniswa nokuba khona kwe-metastases. Ngokuvamile zisakaza ngegazi futhi zithinta amaphaphu, okubangela ukuphefumula, ukukhwehlela, ukuphefumula. Imodi ye-lymphatic yokuhamba kwamaseli aloluhlobo lomdlavuza ayivamile kakhulu.

Ifomu elivame kakhulu le-neoplasm elibulalayo yi-synovial soft tissue sarcoma. Igama lihlotshaniswa nendawo ye-dislocation - i-membrane ye-synovial yamalungu kanye nezinye izinto ezihamba phambili. Izimpawu zaleli gatsha lesi sifo nazo ziyancipha ekusebenzeni komzimba wokubambisana nokubuhlungu obukhulu emisebenzini yomzimba.

Ukwelashwa kwe-tissue sarcoma

Indlela ephumelela kunazo zonke yokwelapha ama-sarcom is ukuhlinzwa. Uma i-sarcoma ihlanganisa imishanguzo emikhulu nemithanjeni, isuse ngokuphelele ingxaki, i-chemotherapy iyinqunywa ngaphezu kwalokho futhi i-radiotherapy ingenziwa. Esikhathini esilandelayo, zonke izinzuzo kanye nokuqapha kufanele zilinganiswe ngokucophelela, ngoba i-irradiation yandisa kakhulu amathuba okuphindaphindiwe. Uma ulawula ukusika nge-scalpel, kungcono kube ukubikezelwa kwe-sarcoma yezicubu ezithambile.

Ngokwesilinganiso, izinga lokusinda kwalesi sifo liphansi kakhulu, ama-50-60% azo zonke iziguli ziyafa zingakapheli unyaka wokuqala ngemuva kokuthola isisu. Enye i-20% yeziguli ezisengozini yokuphindaphinda uhlobo olufanayo lwesisu. Kuze kube manje, kakhulu umkhuba wezinhlobo eziningana ze- chemotherapy enezinhlobonhlobo ezehlukene kuvamile, lokhu kuyinkambiso ephumelela kakhulu, kodwa akuzona zonke izidalwa ezingayithumela.

Kunzima kakhulu ukwelashwa kweziguli ezine-HIV, ezenza ingxenye yengonyama yenani labaguli abane-sarcoma. Uma lesi sifo sitholakale sibhekene nokulimala okuphansi, singadliwa ukuhlinzwa futhi singenzi ukwelashwa okulandelayo, ngoba ngokuvamile kubangele ukucindezelwa kwegciwane lesandulela ngculaza nokunciphisa umsebenzi obalulekile. Uma i-sarcoma yesisindo esithambile iwuhlobo olubi kakhulu, noma yikuphi ukwelashwa ngeke kuphumelele ngenxa yokukhula okusheshayo kwe-tumor kanye ne-metastasis.